Cargando…

Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness

Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarn, Derjung M., Shih, Kevin J., Ober, Allison J., Hunter, Sarah B., Watkins, Katherine E., Martinez, Jeremy, Montero, Alanna, McCreary, Michael, Leamon, Isabel, Sheehe, John, Bromley, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859922/
https://www.ncbi.nlm.nih.gov/pubmed/35906435
http://dx.doi.org/10.1007/s10597-022-01012-x
_version_ 1784874466537373696
author Tarn, Derjung M.
Shih, Kevin J.
Ober, Allison J.
Hunter, Sarah B.
Watkins, Katherine E.
Martinez, Jeremy
Montero, Alanna
McCreary, Michael
Leamon, Isabel
Sheehe, John
Bromley, Elizabeth
author_facet Tarn, Derjung M.
Shih, Kevin J.
Ober, Allison J.
Hunter, Sarah B.
Watkins, Katherine E.
Martinez, Jeremy
Montero, Alanna
McCreary, Michael
Leamon, Isabel
Sheehe, John
Bromley, Elizabeth
author_sort Tarn, Derjung M.
collection PubMed
description Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as “cheating”. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.
format Online
Article
Text
id pubmed-9859922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-98599222023-01-22 Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness Tarn, Derjung M. Shih, Kevin J. Ober, Allison J. Hunter, Sarah B. Watkins, Katherine E. Martinez, Jeremy Montero, Alanna McCreary, Michael Leamon, Isabel Sheehe, John Bromley, Elizabeth Community Ment Health J Original Paper Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as “cheating”. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings. Springer US 2022-07-29 2023 /pmc/articles/PMC9859922/ /pubmed/35906435 http://dx.doi.org/10.1007/s10597-022-01012-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Tarn, Derjung M.
Shih, Kevin J.
Ober, Allison J.
Hunter, Sarah B.
Watkins, Katherine E.
Martinez, Jeremy
Montero, Alanna
McCreary, Michael
Leamon, Isabel
Sheehe, John
Bromley, Elizabeth
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title_full Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title_fullStr Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title_full_unstemmed Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title_short Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
title_sort perspectives regarding medications for opioid use disorder among individuals with mental illness
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859922/
https://www.ncbi.nlm.nih.gov/pubmed/35906435
http://dx.doi.org/10.1007/s10597-022-01012-x
work_keys_str_mv AT tarnderjungm perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT shihkevinj perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT oberallisonj perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT huntersarahb perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT watkinskatherinee perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT martinezjeremy perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT monteroalanna perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT mccrearymichael perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT leamonisabel perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT sheehejohn perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness
AT bromleyelizabeth perspectivesregardingmedicationsforopioidusedisorderamongindividualswithmentalillness